Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

[Alcohol dependence mediated by monoamine neurotransmitters in the central nervous system].

Yang X, Zhang H, Lai J.

Yi Chuan. 2014 Jan;36(1):11-20. Review. Chinese.

PMID:
24846914
2.

Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Harvey RJ, Yee BK.

Nat Rev Drug Discov. 2013 Nov;12(11):866-85. doi: 10.1038/nrd3893. Review.

PMID:
24172334
3.

Glutamatergic targets for new alcohol medications.

Holmes A, Spanagel R, Krystal JH.

Psychopharmacology (Berl). 2013 Oct;229(3):539-54. doi: 10.1007/s00213-013-3226-2. Epub 2013 Sep 1. Review.

4.

Acamprosate suppresses ethanol-induced place preference in mice with ethanol physical dependence.

Kurokawa K, Mizuno K, Shibasaki M, Higashioka M, Oka M, Hirouchi M, Ohkuma S.

J Pharmacol Sci. 2013;122(4):289-98. Epub 2013 Aug 1.

5.

Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Gorini G, Harris RA, Mayfield RD.

Neuropsychopharmacology. 2014 Jan;39(1):104-30. doi: 10.1038/npp.2013.182. Epub 2013 Jul 31. Review.

6.

Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease.

Kong X, Feng D, Mathews S, Gao B.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:56-60. doi: 10.1111/jgh.12032. Review.

7.

Challenges in cancer vaccine development for hepatocellular carcinoma.

Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM.

J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. Review. Erratum in: J Hepatol. 2014 Jan;60(1):237.

8.

The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.

Cooper ME, Regnell SE.

Br J Clin Pharmacol. 2014 Jan;77(1):21-30. doi: 10.1111/bcp.12102. Review.

9.

Agmatine attenuates acquisition but not the expression of ethanol conditioned place preference in mice: a role for imidazoline receptors.

Sameer SM, Chakraborty SS, Ugale RR.

Behav Pharmacol. 2013 Apr;24(2):87-94. doi: 10.1097/FBP.0b013e32835efc46.

PMID:
23399882
10.

Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.

Bishayee A, Thoppil RJ, Waghray A, Kruse JA, Novotny NA, Darvesh AS.

Curr Cancer Drug Targets. 2012 Nov 1;12(9):1191-232. Review.

PMID:
22873222
11.

Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.

Davies DL, Bortolato M, Finn DA, Ramaker MJ, Barak S, Ron D, Liang J, Olsen RW.

Alcohol Clin Exp Res. 2013 Jan;37(1):8-15. doi: 10.1111/j.1530-0277.2012.01846.x. Epub 2012 Jun 4. Review.

12.

Novel medication targets for the treatment of alcoholism: preclinical studies.

Rezvani AH, Lawrence AJ, Arolfo MP, Levin ED, Overstreet DH.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):151-62. Review.

PMID:
22574676
13.

Cholinergic receptor system as a target for treating alcohol abuse and dependence.

Rahman S, Prendergast MA.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):145-50. Review.

PMID:
22574675
14.

Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.

Barron S, Lewis B, Wellmann K, Carter M, Farook J, Ring J, Rogers DT, Holley R, Crooks P, Littleton J.

Recent Pat CNS Drug Discov. 2012 Aug;7(2):129-44. Review.

PMID:
22574674
15.

Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.

Wang H, Lafdil F, Kong X, Gao B.

Int J Biol Sci. 2011 Apr 27;7(5):536-50. Review.

16.

Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability.

Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A.

Alcohol Clin Exp Res. 2011 Sep;35(9):1635-43. doi: 10.1111/j.1530-0277.2011.01510.x. Epub 2011 Apr 27.

17.

Mechanisms and cell signaling in alcoholic liver disease.

Beier JI, McClain CJ.

Biol Chem. 2010 Nov;391(11):1249-64. doi: 10.1515/BC.2010.137. Review.

18.

Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene.

Koilan S, Hamilton D, Baburyan N, Padala MK, Weber KT, Guntaka RV.

Oligonucleotides. 2010 Oct;20(5):231-7. doi: 10.1089/oli.2010.0244. Epub 2010 Sep 6.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk